SUBSCRIPTION AGREEMENT – DEBT SETTLEMENTSubscription Agreement • December 16th, 2013 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledDecember 16th, 2013 Company Industry JurisdictionAhmad Doroudian (the “Subscriber”) wishes to subscribe for 35,000,000 shares of common stock in the capital stock of the Company (the “Shares”), at a deemed price of $0.001 per Share, for an aggregate cost of $35,000;